1. Division of Cancer Immunotherapy Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan
2. Department of Pharmacology School of Medicine Teikyo University Tokyo Japan
3. BrightPath Biotherapeutics Co., Ltd Chiyoda‐ku Japan